Serologic Tests for Lyme Disease: More Smoke and Mirrors
Open Access
- 15 October 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (8) , 1111-1112
Abstract
TO THE EDITOR—The article by Steere et al. describing serologic testing for Lyme disease contains the following conclusion: “the sensitivity of 2-tier testing in patients with later manifestations of Lyme disease was 100%, and the specificity was 99%” [1, p. 192]. This conclusion is both disingenuous and misleading.Keywords
This publication has 17 references indexed in Scilit:
- Prospective Study of Serologic Tests for Lyme DiseaseClinical Infectious Diseases, 2008
- Evaluation of Two Commercial Systems for Automated Processing, Reading, and Interpretation of Lyme Borreliosis Western BlotsJournal of Clinical Microbiology, 2008
- Searching for autoimmunity in “antibiotic-refractory” Lyme arthritisMolecular Immunology, 2008
- Persistence ofBorrelia burgdorferifollowing Antibiotic Treatment in MiceAntimicrobial Agents and Chemotherapy, 2008
- Detection of Borrelia burgdorferi sensu lato DNA by PCR in serum of patients with clinical symptoms of Lyme borreliosisFEMS Microbiology Letters, 2008
- A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathyNeurology, 2008
- Let's tackle the testingBMJ, 2007
- Counterpoint: Long-Term Antibiotic Therapy Improves Persistent Symptoms Associated with Lyme DiseaseClinical Infectious Diseases, 2007
- Chronic infection in ‘post-Lyme borreliosis syndrome’International Journal of Epidemiology, 2005
- The Western Immunoblot for Lyme Disease: Determination of Sensitivity, Specificity, and Interpretive Criteria with Use of Commercially Available Performance PanelsClinical Infectious Diseases, 1997